Atenolol and fetal growth in pregnancies complicated by hypertension

American Journal of Hypertension

Volumn 12, Issue 6, 1999, Pages 541-547

  Lydakis, Charalampos ^a   Lip, Gregory Y H ^a   Beevers, Michèle ^a   Beevers, D Gareth ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Antihypertensive drugs; Atenolol; Fetal growth retardation; Pregnancy

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; LABETALOL; METHYLDOPA; OXPRENOLOL;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FETUS GROWTH; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMALL FOR DATE INFANT;

ADULT; ANTIHYPERTENSIVE AGENTS; ATENOLOL; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; HUMANS; HYPERTENSION; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 0033003102     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00031-X     Document Type: Article

References (31)

1. Eliahou H.E., Silverberg D.S., Reisin E., et al. Propanolol for the treatment of hypertension in pregnancy. Br J Obstet Gynaecol. 85:1978;431-436.
2. Tcherdakoff P.H., Colliard M., Berrard E., et al. Propanolol in hypertension during pregnancy. Br Med J. 2:1978;670.
3. Bott-Kanner G., Schweitzer A., Reisner S.H., et al. Propanolol and hydralazine in the management of essential hypertension in pregnancy. Br J Obstet Gynaecol. 87:1980;110-114.
4. Wichman K., Ryden G., Karlberg B.E. A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy. Scand J Clin Lab Invest. 169:1984;90-94.
5. Sandstrom B. Antihypertensive treatment with the adrenergic beta-receptor blocker metoprolol during pregnancy. Gynecol Obstet Invest. 9:1978;195-204.
6. Gallery E.D.M., Ross M.E., Gyory A.Z. Antihypertensive treatment in pregnancy analysis of different responses to oxprenolol and methyldopa . Br Med J. 291:1985;563-566.
7. Fidler J., Smith V., Fayers P., De Swiet M. Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. Br Med J. 286:1983;1927-1930.
8. Montan S., Ingemarsson I., Marsal K., Sjoberg N. Randomised controlled trial of atenolol and pindolol in human pregnancy effect on fetal haemodynamics . Br Med J. 304:1992;946-949.
9. Sibai B.M., Mabie W.C., Shamsa F., et al. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol. 162:1990;960-967.
10. Mabie W.C., Gonzalez A.R., Sibai B.M., Amon E. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol. 70:1987;328-333.
11. Pickles C.J., Symonds E.M., Pipkin F.B. The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy induced hypertension. Br J Obstet Gynaecol. 96:1989;38-43.
12. Rubin P.C., Butters L., Clark D.M., et al. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet. i:1983;431-434.
13. Butters L., Kennedy S., Rubin P.C. Atenolol in essential hypertension during pregnancy. Br Med J. 301:1990;587-589.
14. Redman C.W.G. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet. 2:1976;753-756.
15. Weitz C., Khouzami V., Maxwell K., Johnson J.W. Treatment of hypertension in pregnancy with methyldopa a randomised double blind study . Int J Gynaecol Obstet. 25:1987;35-40.
16. Constantine G., Beevers D.G., Reynolds A.L., Luesley D.M. Nifedipine as a second line antihypertensive drug in pregnancy. Br J Obstet Gynecol. 94:1987;1136-1142.
17. Fenakel K., Fenakel G., Appleman Z., et al. Nifedipine in the treatment of severe pre-eclampsia. Obstet Gynecol. 77:1991;331-337.
18. Plouin P.-F., Breart G., Llado J., et al. A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancy-induced hypertension. Br J Obstet Gynaecol. 97:1990;134-141.
19. Hutton J.D., James D.K., Stirrat G.M., et al. Management of severe pre-eclampsia and eclampsia by UK consultants. Br J Obstet Gynaecol. 99:1992;554-556.
20. Lip G.Y.H., Beevers M., Churchill D., et al. Effect of atenolol on birth weight. Am J Cardiol. 79:1997;1436-1438.
21. 1993 guidelines for the management of mild hypertension memorandum from a World Health Organization/International Society of Hypertension meeting . J Hypertens. 11:1993;905-918.
22. Davey D.A., MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 158:1988;892-898.
23. Tin W., Wariyar U.K., Hey E.N. Selection biases invalidate current low birthweight weight-for-gestation standards. Br J Obstet Gynaecol. 104:1997;180-185.
24. Fay R.A., Dey P.L., Saadie C.M.J., et al. Ponderal index a better definition of the "at risk" group with intrauterine growth problems than birth-weight for gestational age in term infants . Aust NZ Obstet Gynaecol. 31:1991;17-19.
25. Kjellmer I., Dagbjartsson A., Hrebk A., et al. Maternal beta-adrenoceptor blockade reduces fetal tolerance to asphyxia. Acta Obstet Gynecol Scand. (suppl 118):1984;S75-S80.
26. Karlsson K., Lundgren Y., Ljungblad U. The acute effects of non-selective b-adrenergic blocking agents in hypertensive rats. Acta Obstet Gynecol Scand. (suppl 118):1984;S81-S84.
27. Sibai B.M., Gonzalez A.R., Mabie W.C., Morettini M. A comparison of labetalol plus hospitalisation versus hospitalisation alone in the management of preeclampsia remote from term. Obstet Gynecol. 70:1987;323-327.
28. Redman CWG: A controlled trial of the treatment of hypertension in pregnancy: labetalol compared with methyldopa, in Riley A, Symonds EM (eds): Investigation of Labetalol in the Management of Hypertension in Pregnancy. International Congress Series 591, Amsterdam, Excerpta Medica, 1982, pp 101-110.
29. Rubin P.C., Butters L., Clark D., et al. Obstetric aspects of the use in pregnancy-associated hypertension of the β-adrenoceptor antagonist atenolol. Am J Obstet Gynecol. 150:1984;389-392.
30. Rubin P.C., Butters L., Low R.A., Reid J.L. Atenolol in the treatment of essential hypertension during pregnancy. Br J Clin Pharmacol. 14:1982;279-281.
31. Paran E., Holzberg G., Mazor M., et al. Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension. Int J Clin Pharm Therapeu. 33:1995;119-123.